Early platelet count kinetics has prognostic value in lower-risk myelodysplastic syndromes

about

Early platelet count kinetics has prognostic value in lower-risk myelodysplastic syndromes

Item

http://www.wikidata.org/entity/Q58734670

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Early platelet count kinetics ...... risk myelodysplastic syndromes

@en

Early platelet count kinetics ...... risk myelodysplastic syndromes

@nl

type

Item

label

Early platelet count kinetics ...... risk myelodysplastic syndromes

@en

Early platelet count kinetics ...... risk myelodysplastic syndromes

@nl

prefLabel

Early platelet count kinetics ...... risk myelodysplastic syndromes

@en

Early platelet count kinetics ...... risk myelodysplastic syndromes

@nl

P1476

Early platelet count kinetics ...... risk myelodysplastic syndromes

@en

P2093

Agnes Guerci-Bresler

http://www.w3.org/2001/XMLSchema#string

Aleksandar Savic

http://www.w3.org/2001/XMLSchema#string

Alex Smith

http://www.w3.org/2001/XMLSchema#string

Antonio Medina Almeida

http://www.w3.org/2001/XMLSchema#string

Argiris Symeonidis

http://www.w3.org/2001/XMLSchema#string

Aurelia Tatic

http://www.w3.org/2001/XMLSchema#string

Chiara Elena

http://www.w3.org/2001/XMLSchema#string

Corine van Marrewijk

http://www.w3.org/2001/XMLSchema#string

David Bowen

http://www.w3.org/2001/XMLSchema#string

Dominic Culligan

http://www.w3.org/2001/XMLSchema#string

P2860

The World Health Organization (WHO) classification of the myeloid neoplasms

International scoring system for evaluating prognosis in myelodysplastic syndromes

Regularization Paths for Generalized Linear Models via Coordinate Descent

Relationship of treatment-related cytopenias and response to lenalidomide in patients with lower-risk myelodysplastic syndromes.

Platelet counts and haemorrhagic diathesis in patients with myelodysplastic syndromes.

Basic concepts and methods for joint models of longitudinal and survival data.

Cytomorphology review of 100 newly diagnosed lower-risk MDS patients in the European LeukemiaNet MDS (EUMDS) registry reveals a high inter-observer concordance.

Stability of hematologic parameters in healthy subjects. Intraindividual versus interindividual variation.

Revised international prognostic scoring system for myelodysplastic syndromes.

Platelet count doubling after the first cycle of azacitidine therapy predicts eventual response and survival in patients with myelodysplastic syndromes and oligoblastic acute myeloid leukaemia but does not add to prognostic utility of the revised IP

P304

2079-2089

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOODADVANCES.2018020495

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Pierre Fenaux

Ulrich Germing

P577

2018-08-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30126931

http://www.w3.org/2001/XMLSchema#string

P932

6113605

http://www.w3.org/2001/XMLSchema#string